Zinc and alcoholic liver disease

Digestive Diseases

Volumn 28, Issue 6, 2010, Pages 745-750

  Zhou, Zhanxiang ^a,b  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b NONE   (United States)

Author keywords

Alcohol metabolism; Alcohol induced hepatic inflammation; Apoptosis; Hepatic lipid metabolism regulation; Hepatocyte nuclear factor 4 ; Metallothionein; Oxidative stress; Peroxisome proliferation activator ; Zinc homeostasis

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; CYTOCHROME P450 2E1; FATTY ACID; METALLOTHIONEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; ZINC;

ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GENE OVEREXPRESSION; HEPATOMA CELL; KNOCKOUT MOUSE; LIPID METABOLISM; LIPID STORAGE; LIVER TOXICITY; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

ANIMALS; HUMANS; LIPID METABOLISM; LIVER; LIVER DISEASES, ALCOHOLIC; METALLOTHIONEIN; OXIDATIVE STRESS; ZINC;

EID: 79955585388     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324282     Document Type: Article

References (41)

1. McClain CJ, Antonow DR, Cohen DA, Shedlofsky S: Zinc metabolism in alcoholic liver disease. Alcohol Clin Exp Res 1986; 10: 582-589. (Pubitemid 17226976)
2. Dinsmore W, Callender ME, McMaster D, Todd SJ, Love AH: Zinc absorption in alcoholics using zinc-65. Digestion 1985; 32: 238-342.
3. Kägi JH: Overview of metallothionein. Methods Enzymol 1991; 205: 613-626.
4. Davis SR, Cousind RJ: Metallothionein expression in animals: a physiological perspective on function. J Nutr 2000; 130: 1085-1088. (Pubitemid 30233251)
5. Thornalley PJ, Vasak M: Possible role for metallothionein in protection against radiation- induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 1985; 827: 36-44. (Pubitemid 15125549)
6. Iszard MB, Liu J, Liu Y, Dalton T, Andrews GK, Palmiter RD, Klaassen CD: Characterization of metallothionein-I-transgenic mice. Toxicol Appl Pharmacol 1995; 133: 305-312.
7. Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD: Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci USA 1994; 91: 584-588. (Pubitemid 24041446)
8. Kang YJ: The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 1999; 222: 263-273. (Pubitemid 129784088)
9. Zhou Z, Sun X, James Kang Y: Metallothionein protection against alcoholic liver injury through inhibition of oxidative stress. Exp Biol Med 2002; 227: 214-222.
10. Zhou Z, Sun X, Lambert JC, Saari JT, Kang YJ: Metallothionein-independent zinc protection from alcoholic liver injury. Am J Pathol 2002; 160: 2267-2274. (Pubitemid 34663417)
11. Lieber CS: Alcohol metabolism, cirrhosis and alcoholism. Clin Chim Acta 1997; 257: 59-84.
12. McClearn GE, Bernett EL, Hebert M, Kakehana R, Schlesinger K: Alcohol dehydrogenase activity and previous ethanol consumption in mice. Nature 1964; 203: 793-794.
13. Cederbaum AI, Lu Y, Wu D: Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 2009; 83: 519-548.
14. Parat MO, Richard MJ, Beani JC, Favier A: Involvement of zinc in intracellular oxidant/ antioxidant balance. Biol Trace Elem Res 1997; 60: 187-204. (Pubitemid 28086463)
15. Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, Kang YJ: Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 2005; 166: 1681-1690. (Pubitemid 40734391)
16. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ: Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001; 34: 248-253. (Pubitemid 32176446)
17. Ziol M, Tepper M, Lohez M, Arcangeli G, Ganne N, Christidis C, Trinchet JC, Beaugrand M, Guillet JG, Guettier C: Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001; 34: 254-260. (Pubitemid 32176447)
18. Meerarani P, Ramadass P, Toborek M, Bauer HC, Bauer H, Hennig B: Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor-α Am J Clin Nutr 2000; 71: 81-87. (Pubitemid 30033588)
19. Nakatani T, Tawaramoto M, Opare Kennedy D, Kojima A, Matsui-Yuasa I: Apoptosis induced by chelation of intracellular zinc is associated with depletion of cellular reduced glutathione level in rat hepatocytes. Chem Biol Interact 2000; 125: 151-163. (Pubitemid 30145625)
20. Cao J, Bobo JA, Liuzzi JP, Cousins RJ: Effects of intracellular zinc depletion on metallothionein and ZIP2 transporter expression and apoptosis. J Leukoc Biol 2001; 70: 559-566. (Pubitemid 32958555)
21. Bao S, Knoell DL: Zinc modulates airway epithelium susceptibility to death receptormediated apoptosis. Am J Physiol Lung Cell Mol Physiol 2006; 290:L433-L441. (Pubitemid 43725087)
22. Lambert JC, Zhou Z, Kang YJ: Suppression of Fas-mediated signaling pathway is involved in zinc inhibition of ethanol-induced liver apoptosis. Exp Biol Med 2003; 228: 406-412. (Pubitemid 37203648)
23. Zhou Z, Kang X, Jiang Y, Song Z, Feng W, McClain CJ, Kang YJ: Preservation of hepatocyte nuclear factor-4α is associated with zinc protection against TNF-α hepatotoxicity in mice. Exp Biol Med 2007; 232: 622-628. (Pubitemid 46683387)
24. Zhou Z, Liu J, Song Z, McClain CJ, Kang YJ: Zinc supplementation inhibits hepatic apoptosis in mice subjected to a long-term ethanol exposure. Exp Biol Med 2008; 233: 540-548. (Pubitemid 351657355)
25. Purohit V, Russo D, Coates PM: Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium. Alcohol 2004; 34: 3-8.
26. Lakshman MR: Some novel insights into the pathogenesis of alcoholic steatosis. Alcohol 2004; 34: 45-48.
27. Nagy LE: Molecular aspects of alcohol metabolism: transcription factors involved in early alcohol-induced liver injury. Annu Rev Nutr 2004; 24: 55-78. (Pubitemid 38938786)
28. Crabb DW, Liangpunsakul S: Alcohol and lipid metabolism. J Gastroenterol Hepatol 2006; 21:S56-S60. (Pubitemid 44266552)
29. Tomita K, Azuma T, Kitamura N, Tamiya G, Ando S, Nagata H, Kato S, Inokuchi S, Nishimura T, Ishii H, Hibi T: Leptin deficiency enhances sensitivity of rats to alcoholic steatohepatitis through suppression of metallothionein. Am J Physiol Gastrointest Liver Physiol 2004; 287:G1078-G1085. (Pubitemid 39423701)
30. Tom Dieck H, Döring F, Fuchs D, Roth HP, Daniel H: Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. J Nutr 2003; 133: 1004-1010. (Pubitemid 36407117)
31. Tom Dieck H, Döring F, Roth HP, Daniel H: Transcriptome and proteome analysis identifies the pathways that increase hepatic lipid accumulation in zinc-deficient rats. J Nutr 2005; 135: 199-205 (Pubitemid 40194478)
32. Yousef MI, El-Hendy HA, El-Demerdash FM, Elagamy EI: Dietary zinc deficiency induced- changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 2002; 175: 223-234. (Pubitemid 34615716)
33. Kang X, Zhong W, Liu J, Song Z, McClain CJ, Kang YJ, Zhou Z: Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor- 4 alpha; and peroxisome proliferator-activated receptor- alpha; Hepatology 2009; 50: 1241-1250.
34. Staudinger JL, Lichti K: Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease. Mol Pharm 2008; 5: 17-34. (Pubitemid 351300031)
35. Nagy LE: Molecular aspects of alcohol metabolism: transcription factors involved in early alcohol-induced liver injury. Annu Rev Nutr 2004; 24: 55-78. (Pubitemid 38938786)
36. Crabb DW, Galli A, Fischer M, You M: Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor-α Alcohol 2004; 34: 35-38.
37. Fischer M, You M, Matsumoto M, Crabb DW: Peroxisome proliferator- activated receptor-α (PPAR-α) agonist treatment reverses PPAR-α dysfunction and abnormalities in hepatic lipid metabolism in alcoholfed mice. J Biol Chem 2003; 278: 27997-28004. (Pubitemid 36899995)
38. Watt AJ, Garrison WD, Duncan SA: HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 2003; 37: 1249-1253. (Pubitemid 36667301)
39. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA: Control of pancreas and liver gene expression by HNF transcription factors. Science 2004; 303: 1378-1381. (Pubitemid 38269432)
40. Webster KA, Prentice H, Bishopric NH: Oxidation of zinc finger transcription factors: physiological consequences. Antioxid Redox Signal 2001; 3: 535-548. (Pubitemid 32785979)
41. Wilcox DE, Schenk AD, Feldman BM, Xu Y: Oxidation of zinc-binding cysteine residues in transcription factor proteins. Antioxid Redox Signal 2001; 3: 549-564. (Pubitemid 32785980)